Artificial pancreas (AP) clinical trial participants' acceptance of future ap technology

Diabetes Technology and Therapeutics

Volumn 16, Issue 9, 2014, Pages 590-595

  Bevier, Wendy C ^a   Fuller, Serena M ^b   Fuller, Ryan P ^b   Rubin, Richard R ^c   Dassau, Eyal ^a,d,e   Doyle, Francis J ^a,d,e   Jovanovič, Lois ^a,d,e   Zisser, Howard C ^a,d  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of California   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ADULT; ALTRUISM; ARTICLE; ARTIFICIAL PANCREAS; ATTITUDE TO HEALTH; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; FEMALE; FUTUROLOGY; HUMAN; INSULIN PUMP; MALE; MEDICAL TECHNOLOGY; MOTIVATION; NONHUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; RELIABILITY; DIABETES MELLITUS, TYPE 1; PATIENT ATTITUDE; PERCEPTION; PILOT STUDY; QUESTIONNAIRE; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA;

DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PANCREAS, ARTIFICIAL; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PERCEPTION; PILOT PROJECTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84906335085     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0365     Document Type: Article

References (26)

1. Mehta SN, Wolfsdorf JI: Contemporary management of patients with type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:573-593.
2. Zisser H, Jovanovic L, Doyle F III, Ospina P, Owens C: Run-to-run control of meal-related insulin dosing. Diabetes Technol Ther 2005;7:48-57.
3. Palerm CC, Rodriguez-Fernandez M, Bevier WC, Zisser H, Banga JR, Jovanović L, Doyle FJ III: Robust parameter estimation in a model for glucose kinetics in type 1 diabetes subjects. Conf Proc IEEE Eng Med Biol Soc 2006;1:319-322.
4. Zisser HC, Bevier WC, Jovanović L: Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus. Diabetes Technol Ther 2007;9:509-515.
5. Bevier WC, Zisser HC, Jovanović L, Finan DA, Palerm CC, Seborg DE, Doyle FJ III: Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone. J Diabetes Sci Technol 2008;2:578-583.
6. Finan DA, Doyle FJ III, Palerm CC, Bevier WC, Zisser HC, Jovanović L, Seborg DE: Experimental evaluation of a recursive model identification technique for type 1 diabetes. J Diabetes Sci Technol 2009;3:1192-1202.
7. Harvey RA, Wang Y, Grosman B, Percival MW, Bevier W, Finan DA, Zisser H, Seborg DE, Jovanović L, Doyle III FJ, Dassau E: Quest for the artificial pancreas: combining technology with treatment. IEEE Eng Med Biol Mag 2010;29:53-62.
8. Zisser H, Breton M, Dassau E, Markova K, Bevier W, Seborg D, Kovatchev B: Novel methodology to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system. J Diabetes Sci Technol 2011;5:1509-1518.
9. Harvey RA, Dassau E, Bevier WC, Seborg DE, Jovanović L, Doyle III FJ, Zisser HC: Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system. Diabetes Technol Ther 2014;16:348-357.
10. Dassau E, Zisser H, Harvey RA, Percival MW, Grosman B, Bevier W, Atlas E, Miller S, Nimri R, Jovanović L, Doyle III FJ: Clinical evaluation of a personalized artificial pancreas. Diabetes Care 2013;36:801-809.
11. Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A: Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technol 2009;3:1014-1021.
12. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011;342:d1855.
13. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M: MDLogic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010;33:1072-1076.
14. Renard E, Place J, Cantwell M, Chevassus H, Palerm CC: Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas. Diabetes Care 2010;33:121-127.
15. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B: Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol 2009;3:1031-1038.
16. van Bon AC, Kohinor MJ, Hoekstra JB, von Basum G, deVries JH: Patients' perception and future acceptance of an artificial pancreas. J Diabetes Sci Technol 2010;4:596-602.
17. Gonder-Frederick L, Shepard J, Peterson N: Closed-loop glucose control: psychological and behavioral considerations. J Diabetes Sci Technol 2011;5:1387-1395.
18. van Bon AC, Brouwer TB, von Basum G, Hoekstra JB, DeVries JH: Future acceptance of an artificial pancreas in adults with type 1 diabetes. Diabetes Technol Ther 2011;13: 731-736.
19. Elleri D AC, Allen JM, Hayes J, Pesterfield C, Wilinska ME, Dunger DB, Hovorka R: Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. Diabetes Technol Ther 2010;12:35-39.
20. Shepard JA, Gonder-Frederick L, Vajda K, Kovatchev B: Patient perspectives on personalized glucose advisory systems for type 1 diabetes management. Diabetes Technol Ther 2012;14:858-861.
21. Davis FD: Perceived usefulness, perceived ease of use, and user acceptance of information technology. MISQ 1989;13: 319-40.
22. Holden RJ, Karsh BT: The technology acceptance model: its past and its future in health care. J Biomed Inform 2010;43:159-172.
23. Peyrot M, Harshaw Q, Shillington AC, Xu Y, Rubin RR: Validation of a tool to assess medication treatment satisfaction in patients with type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ). Diabet Med 2012;29:1060-1066.
24. Jones JM, Nyhof-Young J, Moric J, Friedman A, Wells W, Catton P: Identifying motivations and barriers to patient participation in clinical trials. J Cancer Educ 2006;21:237-242.
25. Locock L, Smith L: Personal benefit, or benefiting others? Deciding whether to take part in clinical trials. Clin Trials 2011;8:85-93.
26. Chase HP, Beck RW, Xing D, TamborlaneWV, Coffey J, Fox LA, Ives B, Keady J, Kollman C, Laffel L, Ruedy KJ: Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther 2010;12:507-515.